Tenax Therapeutics Inc. (TENX) Plummeted To A New Low On Study Results

Tenax Therapeutics Inc. (TENX) announced Tuesday morning that its Phase 3 LEVO-CTS trial did not achieve statistically significant reductions in the dual endpoints of the study.

from RTT - Before the Bell http://ift.tt/2jCEiQs
via IFTTT